Home LiteratureArticle Details
PMID: 7361221 Published · ppublish English Journal Article

Infections following burn injury.

The Surgical clinics of North America ·Vol. 60 ·No. 1 ·1980-02-00 ·Pages 185-96

MacMillan BG

Abstract

Those factors that have contributed most to the control of burn wound sepsis in the burn patient since 1930 have been the advent of penicillin, the institution of burn center care, the availability of aminoglycosides and antifungal agents, the advent of topical therapy, the aggressive treatment of the burn wound by excisional therapy, a better understanding of respiratory therapy, the support of immune competence, and the recognition of the importance of nutritional support (Fig. 1). At the Shriners Cincinnati Unit, the extent of burn associated with a survival rate of 50 per cent has risen from 70 per cent in 1970 to 80 per cent in 1978. The better chance of survival for burn patients during this period can be directly related to a progressive improvement in the local and systemic measures available for the control of infection.

MeSH Terms
Burns/complications,microbiology,therapy Gentamicins/therapeutic use Humans Mafenide/therapeutic use Nitrofurazone/therapeutic use Povidone-Iodine/therapeutic use Silver Nitrate/therapeutic use Silver Sulfadiazine/therapeutic use Wound Infection/drug therapy,prevention & control,therapy
Chemicals
Gentamicins Mafenide Povidone-Iodine Silver Nitrate Silver Sulfadiazine Nitrofurazone
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
MacMillan B G
Article Info
Journal
The Surgical clinics of North America
Abbr.
Surg Clin North Am
ISSN
0039-6109
Published
1980-02-00
Pages
185-96
Language
English
Region
United States
NLM ID
0074243
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]